Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human Synaptophysin ELISA Kit (AC2804)
Cat.#: ASET-1393
Specifications
Description Human Synaptophysin ELISA Kit allows for the in vitro quantitative determination of human Synaptophysin concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.188 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.313-20 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1103 Mouse LC3B ELISA Kit (AC2514) Quantitative inquiry ASET-2384 Mouse LECT2 ELISA Kit (AC3795) Quantitative inquiry ASET-1243 Mouse Kisspeptin ELISA Kit (AC2654) Quantitative inquiry ASET-1089 Human Profilin 1 ELISA Kit (AC2500) Quantitative inquiry ASET-1416 Mouse beta Nerve Growth Factor ELISA Kit (AC2827) Quantitative inquiry ASET-1666 Porcine Ghrelin ELISA Kit (AC3077) Quantitative inquiry ASET-1318 Guinea Pig TIMP1 ELISA Kit (AC2729) Quantitative inquiry ASET-1911 Mouse c-Fos ELISA Kit (AC3322) Quantitative inquiry ASET-1901 Mouse CRMP2 ELISA Kit (AC3312) Quantitative inquiry ASET-1170 Human LMOD1 ELISA Kit (AC2581) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket